NHS National Pharmaceuticals Generic Products Wave 15b
NHS England · awarded 16 June 2025 · delivered in East Midlands
Who
| Buyer | NHS England Runcorn |
|---|---|
| Supplier | Not published |
| Category | goods |
| Classification | Pharmaceutical products CPV 33600000 |
| Notice published | 8 August 2025 |
What it is for
NHS National Pharmaceuticals Generic Products - Wave 15b Offer reference number: CM/PHG/23/5698 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. FIND A TENDER (FTS) Reference number: 2025/S 000-005420 Potential periods of call-offs under the framework agreement: CM/PHG/23/5698/01 - Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months) NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months) LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months) CM/PHG/23/5698/02 - Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months) CM/PHG/23/5698/03 - Hospital Only (Housekeeping) Products DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months) DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months) DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months)
Read the original award notice on Contracts Finder →
Other contracts from this buyer
1269 awards on file, worth £50.2bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
Everything NHS England has awarded →
Other contracts won by this supplier
98281 awards on file, worth £834.7bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 9 Jun 2022 | Facilities Management & Workplace Services | Crown Commercial Service | — | £35.0bn |
| 21 Mar 2022 | Construction works and Associated Services 2 / Procure 23 (CWAS2/P23) extended | Crown Commercial Service | — | £30.0bn |
| 29 Oct 2019 | Construction Works and Associated Services | Crown Commercial Service | — | £30.0bn |
| 15 Apr 2025 | Provision of Power Purchasing Agreements | Crown Commercial Service | — | £25.0bn |